Understanding Myeloma: From Diagnosis to Treatment Foundations
Myeloma is a complex blood cancer that affects plasma cells—an essential part of the immune system. In this webcast, we break down what myeloma is, how it develops, and the key signs and symptoms that often lead to diagnosis. We’ll explain the current understanding of risk factors, how the disease behaves in the body, and the tools clinicians use to monitor and assess its progression.
Participants will also learn about today’s treatment landscape, including first-line therapies and emerging drug classes that are shaping the future of myeloma care.
Whether you are newly diagnosed, supporting a loved one, or simply seeking a clearer understanding of this disease, this session will offer practical, reliable information in plain language to help you feel more informed and empowered.
This webcast is led by Holly Lee, MD, PhD, Assistant Professor at the University of Calgary.
Dr. Holly Lee is a clinician-scientist at the University of Calgary with a translational research focus on multiple myeloma and the development of novel immunotherapies. Her research investigates myeloma pathobiology, immunotherapeutic strategies, and the molecular mechanisms underlying treatment resistance. She earned her M.D. from the University of Toronto, followed by residency training in Hematology and a Ph.D in myeloma cancer biology at the University of Calgary. Dr. Lee recently joined the University of Calgary as a clinical assistant professor, where she leads a translational myeloma research laboratory dedicated to advancing therapeutic strategies for patients.
This event was made possible thanks to the support of:
